StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report issued on Monday. The firm issued a sell rating on the stock.
Ayala Pharmaceuticals Stock Performance
ADXS opened at $0.02 on Monday. The company’s 50 day moving average is $0.20 and its 200-day moving average is $0.49. Ayala Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $1.49. The company has a market cap of $852,660.00, a P/E ratio of 0.00 and a beta of 1.55.
Ayala Pharmaceuticals Company Profile
Read More
- Five stocks we like better than Ayala Pharmaceuticals
- Investing in Commodities: What Are They? How to Invest in Them
- First Solar Stock: The Dawn of a New Rally in Share Prices
- Canada Bond Market Holiday: How to Invest and Trade
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- Why Invest in 5G? How to Invest in 5G Stocks
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.